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executive Summary
There is global consensus that transmission of HIV from mother to child can be eliminated. A goal has
been set of eliminating new HIV infections among children (defined as a transmission rate of less than 5
percent) by 2015 (UNAIDS 2011). Many of the countries most affected by mother-to-child transmission
(MTCT) of HIV have adopted this goal. Yet reaching the goal depends on the optimal execution of
each step in a complex cascade of activities. These activities involve testing and counseling for HIV, early
attendance (from 14 weeks of pregnancy) for antenatal care (ANC) to optimize antiretroviral (ARV)
prophylaxis for prevention of mother-to-child transmission (PMTCT), adherence to the drugs, CD4
count testing, and, in breastfeeding populations, retention in the PMTCT program until breastfeeding
cessation, which may be for up to 24 months.
Thus, retaining pregnant and lactating women in PMTCT programs is a critical element in the cascade.
However, there are barriers to retention. They include both facility factors such as staff shortages and the
cost of services and community and individual factors such as the cost of transport for clinic attendance,
lack of male involvement, fear of HIV-related stigma and of potential for physical and psychological
harm, and the lack of knowledge of the importance of the program. Evidence of these barriers is reflected
in the estimate that as of 2012 only 62 percent of pregnant women in low and middle income countries
received the most effective regimens for PMTCT (UNAIDS 2013).
There are limited data on current retention rates, as well as drug adherence. The Elizabeth Glaser Pediatric
AIDS Foundation (EGPAF) carried out a secondary data analysis of patient-level data extracted from
registers in selected countries to assess the extent of and factors associated with retention among women
and infants in the PMTCT program. The study was conducted under the U.S. Agency for International
Development’s (USAID) HIVCore project led by the Population Council.
We constructed retrospective cohorts of HIV-positive pregnant women and their infants by reviewing
facility PMTCT, labor and delivery, post natal care, and laboratory registers/records from the time of the
mother’s initial registration. We then tracked their retention in the program over 10–12 months. Four
countries were selected as examples of countries implementing different models of PMTCT: Rwanda
(Option B), Malawi (Option B+), Kenya (Option A), and Swaziland (Option A).
EGPAF-supported sites were utilized to collect data. In all countries except for Swaziland, sites were
purposively selected and stratified by type of facility (hospital, health center, etc.) and location, (urban/
rural). The selection of sites was also guided by logistical concerns. For example, if a site had only a
limited number of HIV-positive pregnant women in a year (e.g., 10) and involved extensive and expensive
travel, it was not selected. Also, if a site was known to have poorly maintained records, it was also
excluded. In Swaziland, facilities were randomly selected within type of facility (clinic, health center, and
public health unit) and by location (urban or rural). Ultimately, 5 facilities were selected in Rwanda, 14 in
Malawi, 12 in Kenya, and 16 in Swaziland.
In each of these facilities, trained data assistants—guided by standard operating procedures adapted for
that particular country context—traced the selected women and extracted their data from the paper
registers/patient charts. Data were entered on laptops directly into an Epi Info v3 (Swaziland) or MS
Access database designed for this purpose. Mothers newly diagnosed with HIV and with known status
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during the period of October 2010 to March 2012 were identified from the ANC register using their
ANC numbers. Data were then extracted from the following registers: ANC, PMTCT, labor and delivery
(L&D)/maternity, child welfare clinic (CWC), post-natal care (PNC), early infant diagnosis (EID)
registers, pharmacy and follow-up records. The ANC numbers were linked with the pre-antiretroviral
treatment (ART) register to obtain their unique patient number for retrieval of patient files. This was
then combined with ART, pharmacy, and lab registers, which were used to obtain details for the mother’s
characteristics. The maternity, PNC, and HIV-exposed infant (HEI) registers were used to link the
mother-baby pair. The data assistants obtained the infant characteristics from the CWC register, HEI
register, HEI card, and polymerase chain reaction (PCR)/dried blood spot files. Infants with positive PCR
results also had their details obtained from pre-ART, ART, and patient files.
A total of 3,644 records were analyzed in the study—457 records of women in Rwanda, 624 in Malawi,
434 in Kenya, and 2,129 in Swaziland. Retention was defined as clinic attendance at each of various
time points for the mother and for the mother/infant pair separately. Retention rates for mother-infant
pairs were calculated for each time periods; for mothers, retention was calculated based on how many of
the six expected visits they attended. The time points used were: 1) 30 days after entry into the PMTCT
program, 2) at delivery, 3) 6 weeks, 4) 2–4 months, 5) 5–7 months, and 6) 10–12 months post-delivery.
We used generalized estimating equations (GEE) methods to estimate the proportion of mothers
attending each visit with corresponding exact 95 percent CIs, assuming a Poisson distribution and an
unstructured variance covariance matrix. For time points one and two, total number registered was the
denominator. For time points three through six, the denominator was the number of mothers who were
retained at time point two, as delivery date is the reference point for these visits.
We undertook bivariate and multivariate analyses of factors associated with retention using GEE. For
the multivariate analysis we first computed pairwise correlations between independent variables. For any
two pairwise correlations above 0.8, one variable was dropped based on the likely importance of each
variable. For example, number of trained nurses was highly correlated with the number of staff in a health
facility, so we subsequently dropped the number of trained nurses. Variable selection was based on fitting
a sequence of models beginning with a simple model with only an intercept term, and then including one
additional explanatory variable in each successive model. The importance of the additional explanatory
variable was assessed by the difference in deviances between successive models.

Key findings

Among the women we found the highest retention rates at 2–4 months post-delivery in Rwanda, 84
percent (95 percent confidence intervals: 79–89 percent); at 2–4 month post-delivery in Kenya for
women on highly active antiretroviral therapy (HAART), 59 percent (48–73 percent); and at delivery
in Malawi, 62 percent (58–66 percent). Retention rates at 11–13 months post-delivery were 67 percent
(61–74 percent) in Rwanda, 3 percent (1–13 percent) for women on HAART in Kenya, and at 9–10
months post-delivery in Malawi, 18 percent (14–24 percent). We were not able to assess the retention
rates for women in Swaziland as we could not adequately link their ANC and PNC records.
The highest retention rates among the infants were at 2–4 months in Rwanda (89 percent [(85–93
percent)]), at 2–4 months in Malawi (23 percent [(15–34 percent]), at 2–4 months in Kenya (16 percent
[12–21 percent]); and at 6 weeks in Swaziland (80 percent [69–94 percent]). Infant retention rates at
11–13 months were 76 percent (71–81 percent) in Rwanda, 1 percent (0–3 percent) in Kenya, and 6
percent (3–14 percent) in Swaziland; while in Malawi it was 11 percent (14–24 percent) at 9–10 months.
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Except for rural location, the multivariate analyses of selected factors of, for example, ANC visits, number
of HIV-positive pregnant women, types of health workers, and facility deliveries associated with retention
were very contextual and differed for each country. For example, the numbers of ANC clients and doctor
visits were inversely associated with retention among women in Rwanda (odds ratios [ORs]: -1.004,
p<0.001, -1.0001, p<0.001, respectively), while in Malawi ANC visits were positively associated with
retention (OR: 1.18, p<0.001), and in Kenya the number of facility doctors was positively associated with
retention (OR: 1.008, p<0.001). We found no relationship between retention and selected health facility
and infant characteristics in Swaziland. In all countries, key variables were missing data, in some cases
substantial amounts, making that particular variable less useful in the analysis.

Discussion and recommendations

This series of analytical case studies highlighted a number of issues, including low retention rates among
the women, especially at 11–13 months post-partum in Kenya and 9–10 months post-partum in Malawi,
and the inability to estimate retention rates in Swaziland. Also, health facility characteristics may be
important for retention.
In our study, retention refers to a woman being found/retained in a particular facility. However, it is
difficult to track women across facilities or at different clinics in the PMTCT program. If a woman
chooses or is referred to another facility, the data will not indicate that she is retained in the program.
Therefore the lower than expected levels of retention, especially in urban areas, may be related to this
inability to track women across facilities.
It is also difficult to trace women across the multiple registers and files. In order to assess whether a
particular woman was retained, even in a particular facility, she may need to be traced from the ANC
register to the PMTCT register to the labor and delivery register to the postnatal register, etc. There is a
unique identifier (such as an ANC or PMTCT number) to facilitate this process, but since the system
is manual and paper-based, transcription errors may occur. Health care workers have to document
information in these various registers and files, sometimes duplicating the information in several places.
There is also a large number of data fields required. These factors, combined with a limited number
of very busy health workers, lead to missing data and misplaced or lost registers or patient files, and
consequent data quality challenges.
In terms of the facility characteristics and retention, the rural locations were associated with retention, but
this may indicate that rural populations are less mobile than urban populations. The association of rural
location with retention may also indicate that smaller sites are associated with lower workloads and better
patient relations and support. Adequate staffing and active follow up seem to be important factors for
retention.
Improving the patient recording system by reducing the multiple required recording documents and
reducing the number of data elements to the most important ones may improve data quality. One
recommendation is to encourage one integrated patient record. In selected sites, an electronic patient
record surveillance system may prove to be useful. It would be important to have the system be district
based, as opposed to only facility based, so patients can be tracked across facilities. Finally, a system with
smaller sites with lower workloads and service integration with adequate staffing may lead to improved
retention.
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Introduction
There is global consensus that transmission of HIV from mother to child can be eliminated. The Global
Task Team, co-chaired by UNAIDS and the US Office of the Global AIDS Coordinator (OGAC), has
developed a global framework with the goal of eliminating new HIV infections among children (defined
as a transmission rate of less than 5 percent) by 2015 (UNAIDS 2011). Many of the countries most
affected by mother-to-child transmission (MTCT) of HIV have adopted this goal. Yet reaching the goal
depends on the optimal execution of each step in a complex cascade of activities. These activities involve
testing and counseling for HIV, early attendance (from 14 weeks of pregnancy) for antenatal care (ANC)
to optimize antiretroviral (ARV) prophylaxis for prevention of mother-to-child transmission (PMTCT),
adherence to the drugs, CD4 count testing, and, in breastfeeding populations, retention in the PMTCT
program until breastfeeding cessation, which may be for up to 24 months. Retaining pregnant and
lactating women in the PMTCT program is a critical element in the cascade as it is a measure of program
adherence, which is necessary in turn for drug adherence, education, and psychosocial support.
Howevere, there are barriers to the retention of women in the PMTCT program. In low and middle
income countries, only 62 percent of pregnant women were receiving the most effective regimens for
PMTCT in 2012 (UNAIDS 2013). There is, however, a paucity of knowledge even about the extent
of retention, as well as limited information on drug adherence, another critical aspect in the PMTCT
program. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) carried out a secondary data analysis
of patient-level data extracted from registers in selected countries to assess the extent of and factors
associated with retention among women and infants in the PMTCT program. The study was conducted
under the U.S. Agency for International Development’s (USAID) HIVCore project led by the Population
Council.
We used a case study approach where we selected four countries; at the time of the study, Kenya and
Swaziland were implementing the Option A guidelines, Rwanda was implementing the Option B
guidelines, and Malawi was implementing the Option B+ guidelines. Option A guidelines involve CD4
testing of HIV-positive pregnant women: women with low CD4 counts (<350 cells/µl) are treated with
triple highly active antiretroviral therapy (HAART) and women with CD4 counts above that level are
given combination ARV prophylaxis (two ARV drugs); all women are given nevirapine (NVP) prophylaxis
for their breastfeeding infants until a week after their last exposure to breastfeeding, which may be up to
24 months. Option B guidelines recommend providing HAART to all HIV-positive pregnant women
irrespective of CD4 count, and NVP or zidovudine (AZT) for their breastfeeding infants for up to six
weeks of age. Women with CD4 <350/µl, continue HAART for life, while those with CD4 >350/µl
discontinue HAART after cessation of breastfeeding. Option B+ builds on the Option B guidelines by
continuing all HIV-positive pregnant women on HAART for life regardless of CD4 count level.
Retention levels may be affected by the different guidelines. For example, Option B may have lower
levels of retention due to apparently healthy women developing side effects from the toxic ARV drugs. In
Option B+ programs, it may be that women, on learning that they would be required to be on HAART
for life, may decide to leave and not come back, or if they start, they may become lost to follow-up
sooner.
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Rwanda was selected because it had implemented the Option B guidelines for over two years1, and is
regarded as a model country for HIV programming. Though Malawi had only recently fully implemented
Option B+ guidelines (January 20122), it was the only country that at the time was currently rolling out
this program. With the emphasis on and support for Option B+ (WHO 2012), and with more countries
considering this option, or piloting it, it is of critical importance to understand how these new guidelines
may impact retention. Kenya was chosen as an Option A country as it is a large country with variable
rates of HIV prevalence and because it has a mature program, having implemented the guidelines since
July 2010. Swaziland was chosen as another Option A country as it is a small country, also with a mature
program—the guidelines were adopted in July 2010, with fast implementation. It is also a country
that is reported to have reached 90 percent coverage of prevention mother-to-child transmission with
antiretroviral therapy (ART) regimens, and is projected to meet the 2015 targets of virtual elimination of
new child HIV infections if the 30 percent decline from 2009 to 2011 is sustained (UNAIDS 2012). A
central criterion for the selection of countries (except for Malawi3) was that their programs were mature
enough to enable a 12 month post-delivery retrospective analysis so that retention could be assessed over
much of the PMTCT cascade, including breastfeeding.

While Rwanda has since April 2012 elected to now implement Option B+ guidelines, this retrospective chart review
will focus on Option B only.

1

Malawi introduced Option B+ guidelines in July 2011, but only fully implemented them by January 2012.

2

As Malawi had only relatively recently implemented Option B+, we collected data from November 2011, therefore
we have a 12 month post-delivery analysis. We thus limited the review to 9 months post-delivery.

3
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Research questions
Primary research question

What are the levels of and factors related to retention among women and infants in PMTCT care in
purposively selected countries implementing Option A guidelines and those implementing Option B/
B+ guidelines? In this analysis, “retention” was measured by rates of program (clinic) attendance as
documented in the health facility registers.
Specifically:
1. What are the levels of retention 30 days after entry into the PMTCT program, at delivery, 6 weeks, 2
months (60 days), 3 months (90 days), 6, and 12 months post-delivery among women and infants on
Option A and on Option B/B+?
2. How do the levels of retention vary by demographic and clinical characteristics among women and
infants on Option A and on Option B/B+?
3. How do the levels of retention vary by facility characteristics such as type of facility, higher versus
lower volume PMTCT facility, rural/urban facility, and presence and type of follow-up (active/passive)
among women and infants on Option A and on Option B/B+?
4. What are the facility characteristics most associated with retention in Option A and in Option B/B+
sites?

Secondary research questions

1. What are the levels of and factors associated with drug adherence for the women on Option A
guidelines and on Option B/B+ guidelines?
2. What proportion of eligible women is initiated onto HAART and what factors are associated with
initiation?
The last (#2) secondary research question does not apply to Malawi, an Option B+ country, or to
Rwanda, an Option B country, where all HIV-positive positive women are enrolled on HAART.
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Definitions
In this study, retention was defined as clinic attendance for the mother and for the mother/infant pair
separately. Attrition or loss to follow-up was defined as three consecutive missed visits. Type of facility
refers to whether the facility is a hospital, health center (HC), clinic, dispensary (Kenya only), or public
health unit (Swaziland only). There were no mobile facilities. Health facility characteristics refer to type
of facility (hospital, HC, public health unit [PHU]), place of facility (urban/peri-urban/rural), facility size
(number of rooms for maternal and child health (MCH)/PMTCT), staffing levels, vacancy rates, payment
for services, drug stock-outs, availability of CD4 testing on site/elsewhere, CD4 tests turn-around time,
and follow-up mechanisms. Adherence was defined as the proportion of ARV or ART collected from the
pharmacy/health clinic as a proportion of the number of required doses.
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Methodology
We constructed a retrospective cohort of HIV-positive pregnant women and babies using the antenatal
care (ANC), PMTCT, labor and delivery (L&D) child welfare clinic (CWC), postnatal care (PNC),
and early infant diagnosis (EID) registers, as well as pharmacy and follow-up records. We analyzed
data for women enrolled in PMTCT and for their HIV-exposed infants4 over the time period October
2010 to March 2012 from ANC, labor and delivery, PNC, and child welfare registers/patient charts as
appropriate. We also conducted key informant interviews with the health facility managers of the selected
facilities to obtain health facility data.

Study population

The study population was HIV-positive women who accessed PMTCT services at the selected study sites
and their HIV-exposed and HIV-positive infants who received PMTCT services at these study sites.

Sample strategy

EGPAF-supported sites were utilized to collect data. In all countries except for Swaziland, sites were
purposively stratified by type of facility (hospital, HC, etc.) and location, (urban/rural). The selection of
sites was also guided by logistical concerns. Sites were also stratified based on cost of travel, distance to
the site, and number of positive cases. For example, if a site had only 10 HIV-positive pregnant women
in a year and involved extensive and expensive travel5, it would not be selected. Also, if a site was known
to have poorly maintained records, it was also excluded. In some of these countries, test-kit stock-outs are
highly common and it was important to include sites that had a more regular supply of test kits to ensure
the sample size was reached.
In Rwanda, five sites were selected—two urban and three rural hospitals and HCs—based on a minimum
number of 40 HIV-positive pregnant women per site in a year. Consideration of stratification by location
(rural/urban) and type of facility (hospital/health center) with a minimum number of HIV-positive
pregnant women as well as the criteria stated above led to a sample size of only five facilities. Data were
extracted on all the HIV-positive pregnant women who registered at these facilities during the time that
Option B was implemented (November 2010–February 2012).
In Malawi, in addition to the criteria stated above, we stratified by government supported sites and
Christian Health Association of Malawi (church mission) facilities. Participants were randomly sampled.
Initially we counted the total number of possible respondents in the ANC register and divided by the
planned sample size. For example, if the sample size was 20 and we found 40 HIV-positive clients
In Rwanda, Malawi, and Kenya we analyzed data for HIV-positive women enrolled in ANC and their HIV exposed
infants. However, in Swaziland, we enrolled HIV-exposed infants separately, as there was no mother/baby pair
linkage.

4

Distances of at least 20 miles between facilities, with poor or difficulty road conditions, and/or taking two hours to
reach one facility.

5
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registered for the period under study, we divided 40 by 20, which is 2. We then selected every second
eligible client in that particular facility. If there were few clients, they were enrolled serially to reach the
sample size.
In Kenya, retrospective data from all 550 EGPAF-supported sites were initially analyzed to establish the
possible respondents per site. We then ranked and selected the sites based on the volume in each facility;
12 sites with a minimum of 14 newly identified HIV-positive women attending ANC semiannually were
identified. We then stratified by level of facilities: district hospitals, sub-district hospitals, and HCs; one
private facility was also included. At the study sites, the research team counted the respondents from the
ANC register and compared that number with the planned sample size. In low volume sites, respondents
were conveniently selected; beginning with the first registered respondent, while in high volume sites,
respondents were randomly selected until the sample size for each site was reached. Data were extracted
on HIV-positive pregnant women registered for ANC over the period October 2010 to March 2011.
In Swaziland, five hospitals without child welfare clinics were removed from the 113 EGPAF-supported
sites, giving a sampling frame of 108 sites: 97 clinics, 5 HCs, and 6 PHUs. Stratified sampling was used
to select facilities for the study, with five strata identified: rural clinics, urban clinics, rural health centers,
urban health centers, and PHUs (all PHUs in Swaziland are located in urban areas). Sites were then
randomly selected from the strata as follows: six rural clinics, six urban clinics, one rural health center,
one urban health center, and two PHUs. At these sites, data were captured on all HIV-positive pregnant
women who had registered for ANC over the period January 2011 to July 2012.

Sample size

The primary study objective was to estimate rates of attendance at each study visit—30 days after entry
into the PMTCT program, at delivery, 6 weeks, 2 months (60 days), 3 months (90 days), 6, and 12
months post-delivery—among women and infants on Option A, B, B+. The unit of the proposed sample
size was a newly diagnosed or known HIV-positive pregnant woman. Sample sizes were based on the
estimated number of records available and which would be feasible to capture in each country.
In Rwanda the sample size was 474. We sampled from the five health facilities proportional to the
expected number of women who are HIV-positive at ANC. Based on knowledge of retention levels in
Rwanda and the existence of patient files we expected 50 percent of the women to attend the 12 month
visit. Thus the margin of error for 95 percent confidence intervals (CIs) based on the sample size and
expected proportion of women attending the 12 month visit was ±0.044. We interviewed approximately
5–10 health facility managers, speaking to at least one at each facility.
In Malawi our sample size was 500. Based on program implementation reports for Malawi, we expected
50 percent of the women to attend the 9 month visit. Thus the margin of error for 95 percent CIs based
on the sample size and expected proportion of women attending the 9 month visit was ±0.044. We
interviewed approximately 10–15 health facility managers, speaking to at least one at each facility.
In Kenya our sample size was 428. Based on estimates of retention from the routine data, we expected
20 percent of the women to attend the 12 month visit. Thus the margin of error for 95 percent CIs based
on the sample size and expected proportion of women attending the 12 month visit was ±0.038. We
interviewed approximately 10–12 health facility managers, speaking to at least one at each facility.
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In Swaziland, our sample size was 500. We expected 20 percent of the women to attend the 9 month
visit, based on routine data reports. Thus the margin of error for 95 percent CIs based on the sample size
and expected proportion of women attending the 9 month visit is ±0.044. We interviewed 16–25 health
facility managers, speaking to at least one at each facility.
In all the countries except for Swaziland, the number of health facilities was determined by feasibility/
availability of the study population.

Data collection and management

Trained data assistants extracted the data from the paper registers/patient charts and entered them directly
into an Epi Info v3 (Swaziland) or MS Access database designed for this purpose on laptops. Standard
operating procedures were developed to guide the data collection process.
Data were extracted from the following registers: ANC, PMTCT, L&D, CWC, PNC, and EID, as well
as pharmacy and follow-up records. Mothers newly diagnosed with HIV and with known status over the
relevant time periods stated above were identified from the ANC register using their ANC numbers. We
then linked them up with the pre-ART register to obtain their unique patient number for retrieval of
patient files and used ART, pharmacy, and lab registers to obtain details for the mother characteristics.
The maternity, PNC, and HIV-exposed infant (HEI) registers were used to link the mother-baby pair.
The data assistants obtained the infant characteristics from the CWC register, HEI register, HEI card, and
polymerase chain reaction (PCR)/dried blood spot (DBS) files. Infants with positive PCR results also had
their details obtained from pre-ART, ART, and patient files.

Data analysis

Endpoint derivation: The period from the registration date to the end of the observation time was divided
into 6 non-overlapping time segments centered at 30 days after registration, delivery date, 6 weeks, 3
months, 6 months, and 12 months after delivery. For each time interval, a mother/child received “1” if
there was an indication that she made at least one visit to a health center, clinic/hospital, or pharmacy to
pick up drugs and “0” otherwise. For each mother, retention was a count outcome indicating how many
visits were accomplished out of a maximum of six visits that they were expected to attend, so the endpoint
was a total of “1”s received out of “6” expected. Thus to estimate retention 30 days after registration we
examined the first ART receipt date from the registration date. If this date was at 30 days or within 2
weeks after the 30 days, we concluded that the mother was retained. For retention at delivery we used
all possible records that suggested that delivery had occurred; place of delivery, delivery date (where
available), child’s date of birth (if available). If any of these was available, we concluded that the mother
was retained at delivery. For retention after delivery at 2–4 months, 5–7 months, and 11–13 months (for
Rwanda and Kenya) and 9–10 months for Malawi we looked for any indication of ART receipt during
those periods. We analyzed both mothers and infants separately.
Analysis: We used generalized estimating equations (GEE) methods to estimate the proportion of mothers
attending each visit with corresponding exact 95 percent CIs assuming a Poisson distribution and an
unstructured variance covariance matrix. For time points one and two, total number registered was the
denominator. For time points three through six, the denominator was the number of mothers who were
retained at time point two, as delivery date is the reference point for these visits.
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Association: We undertook bivariate and multivariate analyses of factors associated with retention using
GEE. For the multivariate analysis we first computed pairwise correlations between independent variables.
This was to assess for collinearity. For any two pairwise correlations above 0.8, one variable was dropped
based on the likely importance of each variable. Variable selection was based on fitting a sequence of
models beginning with a simple model with only an intercept term, and then including one additional
explanatory variable in each successive model. The importance of the additional explanatory variable was
assessed by the difference in deviances between successive models. All statistical analyses were generated
using SAS/STAT software, Version 9.1 of the SAS System for Windows (SAS Institute Inc., Cary, NC,
USA).

Ethical considerations

All study-related personnel were trained and certified in research ethics, and the data assistants signed
confidentiality agreements before handling data or interacting with the health facility managers. The study
was approved by the Population Council Institutional Review Board (IRB), and by the research ethic
committees/institutional review boards of the four countries. Data were recorded on password protected
laptops and entered into a password protected database. For the analyses, the data were stripped of
individual identifiers.
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Findings
Rwanda
Sample size
Table 1 presents the proposed sample sizes for the records of HIV-positive women to be reviewed versus
the actual sample sizes attained by type of health facility. Overall, 96 percent of the proposed sample size
was reached, with a slight deficit at one of the rural sites. One urban site contributed 45 percent of the
records reviewed, and one of the three rural sites contributed 24 percent of the records.
Table 1: Proposed versus actual sample size by type of health facility
Type of site*
Site #1: Urban
Site #2: Urban
Site #3: Rural
Site #4: Rural
Site #5: Rural
Total

Proposed (women)
N (%)
65 (13.7)
211 (44.5)
44 (9.3)
111 (23.4)
43 (9.1)
474 (100.0)

Actual (women)
N (%)
60 (13.1)
207 (45.3)
43 (9.4)
109 (23.9)
38 (8.3)
457 (96.4)

Actual (infants)†
N (%)
61 (13.2)
210 (45.5)
44 (9.5)
109 (23.6)
38 (8.2)
462 (97.5)

All the sites are health centers
There are more infants than mothers due to multiple births.

*

†

Background characteristics
Women: Table 2 presents the women’s background characteristics and services received. In the records
reviewed, the mean age of the women was 28.6 years, with a mean parity of 2.6. Over 85 percent were
recorded as married or living as married, and only 12 percent had secondary education. About half
(53 percent) were recorded as farmers, and about 30 percent were housewives. However, there was no
information on referral for ART initiation for over half of the women. Only 18 percent were recorded as
having had the recommended four or more ANC visits for this pregnancy. Nearly 60 percent were known
to be HIV-positive at the first ANC visit and nearly 75 percent of the women had a CD4 test result. Of
the cases with recorded WHO stage, 96 percent were WHO stage 1 or 2 (conditions where a presumptive
diagnosis of HIV disease cannot yet be made), at baseline. Information was available on ART for 364
women (80 percent). Among these women, 78 percent were recorded to be on the tenofovir disoproxil
fumarate (TDF) containing regimens and 15 percent on zidovudine (AZT) containing regimens.
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Table 2 Baseline characteristics of the women (N=457)
Variable
Age [n, mean (sd), median (Q1, Q3)]
Parity [n, mean (sd), median (Q1, Q3)]

n

%

455, 28.6 (6.3), 28.5 (23.5, 32.9)
443, 2.6 (1.8), 2.0 (1.0, 4.0)

Marital status (n=455)
Married
Living as married
Single
Divorced/separated
Widowed

203
192
36
22
2

44.6
42.2
7.9
4.8
0.4

Education—highest level completed (n=421)
None
Primary
Secondary

60
310
51

14.3
73.6
12.1

Employment status (n=420)
Farmer
Housewife
Trader
Other

222
123
53
22

52.8
29.3
12.6
5.21

Referral to ART initiating site (n=206)
Yes
No

100
106

48.5
51.5

Number of ANC visits for this pregnancy (n=369)
1
2
3
4 or more

75
101
125
68

20.3
27.4
33.9
18.4

Known HIV positive at first ANC (n=457)
Yes
No

272
185

59.5
40.5

CD4 tested this pregnancy (n=456)
Yes
No

339
117

74.3
25.6

WHO staging at baseline (n=324)
Stage 1
Stage 2
Stage 3 or 4

291
20
13

89.8
6.2
4.0

Type of regimen (n=364)
TDF/3TC/EFV
TDF/3TC/NVP
AZT/3TC/EFV
D4T/3TC/NVP
ABC/3TC/EFV
ABC/3TC/NVP
TDF/3TC/Kaletra
TDF/3TC/ABC

196
84
55
17
5
3
2
1

53.8
23.0
15.1
4.7
1.3
0.8
0.5
0.2

Toxicities/side effects (n=247)
Yes
No

247
4
243

1.6
98.4

Notes: TDF=tenofovir disoproxil fumarate, 3TC= lamivudine, EFV=efavirenz, NVP=nevirapine, AZT=zidovudine,
D4T=stavudine, ABC=abacavir
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Infants: Table 3 presents the background characteristics of the infants. Many of the reconstructed infant
records were missing critical information, including place of delivery (37 percent), as well as mode of
delivery, administration of infant PCR, dispensing of co-trimoxazole (CTX), and infant feeding practices
(over 30 percent for each of these variables).
Table 3 Baseline characteristics of the infants (N=457)
Variable

n

%

Place of delivery (n=290)
Health center
Home

288
2

99.3
0.7

Gender (n=289)
Male
Female

155
134

53.6
46.4

Mode of delivery (n=284)
Normal vaginal delivery
C-section
Other

244
34
6

85.9
12.0
2.1

Infant DNA PCR (n=292)
Yes
No

286
6

97.9
2.1

CTX (n=294)
Yes
No
Not applicable

283
3
8

96.3
1.0
2.7

Mode of feeding (n=285)
Exclusive breastfeeding
Replacement feeding (e.g., bottle feeding)
Not applicable

279
3
3

97.8
1.1
1.1

HIV antibody testing at 18 months (n=254)
Yes
No
Not applicable

111
6
137

43.7
2.4
53.9

Health facilities: All five sampled health facilities were health centers, with one owned by a religious
organization and the remainder government-run public facilities. Table 4 presents selected characteristics
for these health facilities for the year 2011. These characteristics were the number of ANC clients,
HIV-positive pregnant women, facility deliveries, health staff, HIV trained nurses, doctor visits in the
preceding quarter, health staff vacancy rates (defined as the number of filled posts divided by the number
of officially available posts), CD4 testing turn-around-time (TAT), and whether client follow up for nonattendance was begun within a week or not. The number of first-visit ANC clients ranged from 880 to
2,254, and the number of HIV-positive pregnant women ranged from 31 to 156. Deliveries ranged from
393 to 1,086. Only one facility had a vacancy, and all facilities indicated that they had active follow-up
mechanisms, with the follow up starting within a week in three facilities and after more than a week in
two facilities. One facility experienced drug stock outs in the past three months, and four facilities provide
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both adult and pediatric ART services. All facilities provided ART refill and follow-up for PMTCT
services.
Table 4 Description of the health facilities (N=5)
Variable*
No. of ANC clients
No. of HIV+ pregnant women
No. of deliveries
No. of health staff
No. of HIV trained nurses
No. of doctor visits† last quarter
CD4 test TAT‡
Follow up starts <week

Site 1
Urban

Site 2
Urban

Site 3
Urban

Site 4
Rural

Site 5
Rural

Mean (sd)

880
31
393
18
11
0
7
Yes

1,124
34
403
24
10
8
2
Yes

2,254
156
1,086
38
10
14
No

1,885
81
713
35
8
12
3
No

1,350
50
640
31
12
9
7
Yes

1,498.6 (562.4)
70.4 (51.8)
647.0 (283.4)
29.2 (8.2)
10.2 (1.5)
7.3 (5.1)
7
NA

Data for 2011. †Doctors normally visit health facilities for consultation, supervision, and support purposes. ‡Turn-aroundtime (days): This is the amount of time taken from collection of samples at the health facility to the availability of the test
results at the same health facility.

*

Program retention
Health facility retention, women: Table 5 presents the proportion of women that attended at the specified
time periods of 30 days after entry into the PMTCT program; at delivery; 6 weeks, 2–4 months, 5–7
months, and 11–13 months post-delivery. At 12 months post-delivery 67 percent of the women were
retained at the same health facility.
Table 5 Women’s retention by specified time intervals*
n expected
348
348
202
202
202
202

n observed
175
204
151
169
158
136

Time period
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

Prop.
0.51
0.59
0.75
0.84
0.78
0.67

95% CIs
0.46, 0.56
0.54, 0.64
0.69, 0.81
0.79, 0.89
0.73, 0.84
0.61, 0.74

The retention analysis for the women is from 4 instead of the 5 selected health facilities as it was discovered that one
of the facilities (Site #4) was not an ART site during the records review period (2011). This facility referred HIV-positive
women to a nearby hospital for follow up. However, the facility retained the infants for follow-up.

*

Health facility retention, infants: This analysis includes data from all five facilities, as infants from the
facility that referred HIV-positive women to a nearby hospital retained the infants for follow-up. Table 6
shows the infant retention overall. At 6 weeks, only 40 percent of the infants appear to have returned to
the program. However, this increased to 89 percent at 2–4 months, and at 12 months, 76 percent of the
infants were seen.
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Table 6 Infants’ retention at specified time intervals
N expected
348
348
348
348

N observed
140
310
303
265

Time period
6 wks
2–4 m
5–7 m
11–13 m

Prop.
0.40
0.89
0.87
0.76

95% CIs
0.34, 0.46
0.85, 0.93
0.83, 0.91
0.71, 0.81

Demographic and clinical characteristics associated with retention
We investigated whether there was a relationship between retention and demographic and clinical
characteristics of marital status, parity, number of ANC visits, employment, known HIV positivity, and
referral for ART initiation. Tables 7–11 present these findings.
Compared to married women, women who reported that they were living as married had higher retention
levels (p<0.05) at all specified time periods except at delivery, with 64 percent (56–74) retained at 12
months compared to 39 percent (32–48) among the married women (Table 7).
Table 7 Marital status by levels of retention
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

D/S

95% CIs

LM

95% CIs

M

95% CIs

S

95% CIs

p-value

0.27
0.73
0.40
0.33
0.33
0.47

0.14, 0.54
0.56, 0.94
0.22, 0.74
0.16, 0.68
0.16, 0.68
0.27, 0.80

0.52
0.57
0.70
0.82
0.78
0.64

0.47, 0.60
0.51, 0.65
0.62, 0.79
0.75, 0.90
0.70, 0.86
0.56, 0.74

0.29
0.72
0.44
0.48
0.46
0.39

0.23, 0.36
0.66, 0.79
0.36, 0.53
0.40, 0.57
0.38, 0.55
0.32, 0.48

0.42
0.44
0.53
0.60
0.05
0.40

0.28, 0.61
0.31, 0.64
0.33, 0.86
0.40, 0.91
0.27, 0.80
0.22, 0.74

<0.001
0.001
<0.001
<0.001
<0.001
<0.001

D/S: Divorced/separated; LM: Living as married; M: Married; S: Single

Analysis of retention by employment status showed similar retention levels among “housewife” and
“other” employment status, but significant differences between these groups and “farmer” (Table 8).
Table 8 Retention by employment status
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

Farmer

95% CIs

Other*

95% CIs

Housewife

95% CIs

0.29
0.73
0.43
0.45
0.44
0.35

0.23, 0.36
0.68, 0.79
0.36, 0.51
0.38, 0.53
0.37, 0.52
0.29, 0.43

0.51
0.52
0.71
0.76
0.74
0.63

0.41, 0.63
0.42, 0.65
0.58, 0.87
0.64, 0.91
0.61, 0.89
0.50, 0.81

0.49
0.47
0.69
0.86
0.76
0.73

0.41, 0.59
0.39, 0.57
0.58, 0.82
0.78, 0.96
0.66, 0.88
0.62, 0.85

*Includes trader and other.
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Table 9 presents the findings of retention by whether the women were referred to an ART initiating
site. With the exception of delivery, women who were not referred had much higher levels of retention
compared to women who were referred.
Table 9 Referral to ART initiating site by retention levels
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

Yes

95% CIs

No

95% CIs

p-value

0.05
0.80
0.05
0.07
0.09
0.07

0.02, 0.12
0.72, 0.88
0.02, 0.12
0.03, 0.16
0.04, 0.18
0.03, 0.16

0.51
0.71
0.81
0.90
0.84
0.65

0.43, 0.62
0.626, 0.80
0.731, 0.91
0.827, 0.97
0.762, 0.93
0.555, 0.77

<0.001
0.124
<0.001
<0.001
<0.001
<0.001

Table 10 shows the levels of retention in women by ANC visits 1 to 4+. There appears to be no
association between ANC visit and levels of retention.
Table 10 Levels of retention in women by ANC visits
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

1 visit

95% CIs

2 visits

95% CIs

3 visits

95% CIs

4 visits

95% CIs

0.27
0.56
0.36
0.56
0.51
0.39

0.19, 0.39
0.45, 0.68
0.25, 0.54
0.43, 0.73
0.38, 0.68
0.27, 0.57

0.50
0.77
0.67
0.72
0.67
0.63

0.41, 0.61
0.69, 0.86
0.57, 0.78
0.62, 0.83
0.57, 0.78
0.53, 0.75

0.50
0.81
0.48
0.57
0.57
0.42

0.42, 0.60
0.74, 0.88
0.40, 0.59
0.48, 0.67
0.48, 0.67
0.34, 0.53

0.43
0.83
0.55
0.53
0.48
0.42

0.32, 0.56
0.74, 0.93
0.44, 0.70
0.42, 0.68
0.36, 0.63
0.31, 0.58

Table 11 presents levels of retention by women of known HIV status at first ANC. There appears to be no
association between retention and known HIV status.
Table 11 Levels of retention by women of known HIV status
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

Known

95% CIs

Not

95% CIs

0.45
0.65
0.57
0.62
0.60
0.49

0.40, 0.52
0.60, 0.71
0.50, 0.65
0.56, 0.70
0.53, 0.67
0.42, 0.57

0.32
0.60
0.52
0.60
0.55
0.49

0.26, 0.40
0.54, 0.68
0.43, 0.62
0.51, 0.69
0.47, 0.65
0.41, 0.59
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Facility characteristics associated with retention
We used GEE modeling also to assess the facility and other characteristics associated with retention.
The GEE assumes a Poisson distribution with the log link and unstructured variance-covariance for the
dependent variable. As stated earlier, to assess factors associated with retention we first computed pairwise
correlations between independent variables. For any two pairwise correlations above 0.8, one variable
was dropped based on the clinical importance of each variable. Variable selection was based on fitting
a sequence of models beginning with a simple model with only an intercept term, and then including
one additional explanatory variable in each successive model. We considered the following variables:
number of health staff, facility location, number of deliveries in 2011, number of ANC clients in 2011,
total number of HIV-positive pregnant women in 2011, number of trained nurses, number of staff, and
number of doctor visits. Demographic and clinical variables of age, marital status, parity, number of ANC
visits, employment, known HIV positivity, and referral for ART initiation were included in the model
also.
Table 12 presents the findings of the GEE modeling, with the parameter estimates, 95 percent CIs and
p-values, standard errors, and odds ratio (OR). Rural location was positively associated with retention
with an odds ratio of 29.37, as was the number of deliveries in 2011, while the number of ANC clients
and doctor visits in 2011 were inversely related to retention. None of the demographic and clinical factors
was retained in the model.
Table 12 Factors associated with retention
Variable

Intercept
Facility location (rural)
ANC clients 2011
Deliveries 2011
Doctor visits

Parameter
estimate
3.522
3.381
-0.004
0.0015
-0.0001

Standard
error
0.435
0.664
0.0007
0.0005
0.00001

OR

29.37
-1.004
1.001
-1.0001

95% CIs on
parameter
estimates
2.669, 4.375
2.079, 4.682
-0.005, -0.002
1.0004, 1.0025
-1.0001,-1.0001

p-value

<0.001
<0.001
<0.001
0.007
<0.001

Discussion
Our study demonstrated that about 67 percent of HIV-positive pregnant women were retained at 12
months post-partum, which is similar to reports by the Rwanda Ministry of Health (MOH) showing
retention rates of 70 percent (Republic of Rwanda, MOH 2012). The 12-month infant retention rate
was 76 percent; it is possible that this could approximate and be a better proxy for the retention rate of
the women, given that these infants are most likely to be brought by their mothers. In a multi-country
study, McNairy et al. (2013) found that the retention among Rwandan infants on ART was 86 percent
at 12 months. The findings that retention improved in the time periods soon after delivery suggests that
a number of women do not deliver in the facilities they initially attend, returning after delivery for the
follow-up services. Women may prefer to deliver elsewhere due to perceived better services or to be near
their mothers, who may help and support them at this time. However, the fact that many women deliver
elsewhere makes tracking and tracing of the women more challenging, and consideration should be given
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to the development of electronic databases which would allow for the tracing of women at different
facilities, at least within the same region or province.
The higher retention of mothers and infants in rural facilities is suggestive of greater mobility in urban
as compared to rural settings. The association of improved retention with lower facility workload as
measured by the number of ANC clients and the ratio of clinical staff to ANC clients suggests that with a
lower workload, staff may have more time to work with individual clients. Our finding is supported by a
South African study which found that higher clinic patient loads was associated with higher loss to follow
up of ART patients (Fatti et al. 2011).
This study found that women who reported they were living as married had better retention. This may
be a reflection of socioeconomic differences between women or a reflection of social support and male
involvement. Though we were unable to adequately measure this factor, it is likely that the married
women may have been of higher socioeconomic status and subsequently may have either attended other
facilities or been lost to follow up. In general non-married women (single, divorced/separated), had poorer
retention levels than married women (WHO 2010). Lower socioeconomic status has been found to be
unfavorably associated with a number of poorer health outcomes including retention (Panditrao 2011).
The finding that women who stated their employment status as “farmer” had lower levels of retention may
be a reflection of a lower socioeconomic status. Providing comprehensive services in a facility has been
found to improve various outcomes including retention. This is supported by the finding that women
were better retained when they were not referred to another facility. None of these factors, however, was
retained in the final retention model.
Concerning the multivariate analysis of factors associated with retention, the finding of retention being
associated with rural facility location suggests greater mobility in urban as compared to rural settings.
The inverse association of ANC clients, but positive association with number of deliveries, suggests an
association with facilities that may be larger and more comprehensive, where women come to deliver
from other areas. This is supported by the finding that retention is associated with fewer doctor visits,
perhaps because these sites already had adequate numbers of doctors. Sites may have more doctor visits
where there is insufficient staff and doctors, and these sites may tend to be smaller. The Rwandan program
emphasizes the provision of comprehensive care services (UNAIDS 2011).

Malawi
Sample size
Table 13 presents the actual compared with the proposed sample size by type of facility. The sampled
records exceeded the proposed sample size by 21 percent with the largest addition of 90 extra records
among rural/community hospitals, and the addition of three more hospitals. Records sampled from
health centers still constituted the largest proportion (45 percent), though reduced from the proposed 51
percent. A total of 272 records (43 percent) were sampled from the three urban facilities in the study.
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Table 13 Proposed versus actual sample size by type of health facility
Facility type

Proposed sample size
N†
%
N*

Actual sample size
N
N
%

Health center
Rural/community hospital
District hospital
Total

5
3
2
10

6
6
2
14

266
113
140
519

51.3
21.8
26.9
100.0

324
159
141
624

51.9
25.5
22.6
100.0

Facility type, †HIV+ pregnant women at ANC.

*

Background characteristics
Women: In the records reviewed the mean age of the women was 26.8 years, with mean parity at this
pregnancy of two. Table 14 presents the demographic and selected clinical characteristics of the women.
There was no information on marital status or education. There was information on employment status
for 370 (59 percent) of the women. Of these, 78 percent were recorded as housewives and 15 percent
as farmers. Information on referral for ART initiation was available for 416 (67 percent) of the women;
among these, over 95 percent had been referred for ART initiation. About 24 percent of women were
recorded as having had the recommended four or more ANC visits for this pregnancy, and 85 percent
overall were known to be HIV positive at the first ANC visit. The mean gestational age at booking was
22 weeks. There were few data on the WHO clinical staging, as this information was missing for 74
percent of the records. Almost all 609 (98 percent) of the women were on TDF+ lamivudine (3TC)+EFV
(efavirenz) regimen, with this information missing for 11 women.
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Table 14 Baseline characteristics of the women (N=624)
n
Age [n, mean, (sd) median, (Q1, Q3)]

%

608, 26.8 (5.4) 27, (23, 30)

Employment status (n=370)
Housewife
Employed
Farmer
Trader
Other
Unemployed

289
9
55
13
–
4

78.1
2.43
14.9
3.5
–
1.1

Referral to ART initiating site (n=416)
Yes
No

406
10

97.6
2.4

Parity at this pregnancy [n, mean (sd), median, (Q1, Q3)]

599, 2 (1.56) 2, (1, 3)

Number of ANC visits for this pregnancy (n=599)
1
2
3
4 or more

146
148
162
143

24.4
24.7
27.1
23.9

Known HIV positive at first ANC (n=542)
Yes
No

532
10

98.2
1.8

WHO staging at baseline (n=163)
Stage 1
Stage 2
Stage 3 or 4

151
7
5

92.6
4.3
3.1

Gestation weeks [n, mean (sd), median, (Q1, Q3)]

596, 21.9 (6.08), 22, (18, 26)

Infants: Table 15 presents the background characteristics of the infants. About 95 percent of the infants
were born at the health facilities, though for 236 women (38 percent), this information was unknown.
Information on mode of delivery was available for less than half of the infants; where this was available,
96 percent had normal vaginal deliveries. The mean birth weight of the infants was 2,523 grams (5.6
pounds). About 86 percent of the infants had had an infant DNA PCR test done, but these data were
not available for 351 infants (57 percent). Concerning mode of feeding, 89 percent were reported to
be exclusively breastfed, while 6 percent were mixed fed. Again, however, these figures are from limited
data, as for 386 infants (62 percent), this information was missing. About 35 percent were recorded to
have had an HIV antibody test at age 18 months. However, this information was unknown or missing
for 386 infants (62 percent). About 83 percent of the infants were recorded to have received CTX
supplementation; however, this information was unknown for 346 infants (57 percent).
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Table 15 Baseline characteristics of the infants (N=624)
n

%

Place of delivery for first child (n=385)
Health facility
Home
Baby brought alive (to the health facility)

366
10
9

95.1
2.6
2.3

Gender (n=368)
Male
Female

174
194

47.3
52.7

Mode of delivery (n=305)
Normal vaginal delivery
C-section
Breech
Vacuum extraction

293
9
2
1

96.0
3.0
0.7
0.3

Birth weight [n, mean (sd)]

598, 2,523 (608)

Infant DNA PCR (n=264)
Yes
No

226
38

85.6
14.4

Mode of feeding (n=238)
Complementary feeding
Exclusive breastfeeding
Mixed feeding

12
212
14

5.04
89.08
5.88

Infant HIV antibody tested at 18m (n=238)
Yes
No
Not applicable

82
155
1

34.5
65.1
0.4

CTX supplementation (n=261)
Yes
No

216
45

82.8
17.2

Health facilities: Of the 14 facilities that were surveyed, seven were primary level facilities, five secondary
level and two tertiary level (Table 16). In 2012, the median number of ANC clients in these facilities
was 2,395, while the median number of HIV-positive pregnant women was 88. The median number
of deliveries in the 6 facilities in which this indicator was analyzed was 2,147, and 11 of the 14 health
facilities were located in rural/semi-urban areas. There was a median number of 10 health staff and 13
trained nurses per facility. All 14 health facilities provided maternity services, and they all provided both
adult and pediatric ART services. ART drug stock outs in the last three months had been experienced
by about a third (five) of the facilities, and eight facilities indicated that they had active follow-up
mechanisms for clients on ART. However, there were no data on when the follow up started (within a
week or later).
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Table 16 Description of the health facilities (N=14)
n
Type of facility
Community/rural hospital
District hospital
Health center

6
2
6

Number of ANC clients 2012 [n, mean (sd), median, (Q1, Q3)] 14, 2946.93 (1571.52), 2395, (1810, 3916)
Number of HIV+ pregnant women 2012 [n, mean (sd),
14, 142(145), 87.5, (53, 143)
median, (Q1, Q3)]
Number of deliveries [n, mean (sd), median, (Q1, Q3)]
6, 2564 (1569.43), 2147.5, (1270, 3618)
Place of facility
Rural
Urban
Number of health staff [n, mean (sd), median, (Q1,Q3)]
Number of HIV trained nurses [n, mean (sd), median, (Q1,
Q3)]
Number of clinical officer [n, mean (sd), median, (Q1, Q3)]
Vacancy rate [n, median (sd), (Q1, Q3)]
Number of trained health care workers [n, mean (sd), median,
(Q1, Q3)]
Number of medical doctors [n, mean (sd), median, (Q1, Q3)]
Number of medical assistant [n, mean (sd), median, (Q1, Q3)]
Number of PNC clients [n, mean (sd), median, (Q1, Q3)]
Maternity services provided
Yes
No
ART drug stock outs last 3 months
Yes
No

11
3
12, 10.91 (7.48), 10, (4.5, 16)
14, 22.78 (23.26), 12.5, (8, 31)
14, 4.42 (7.32), 1.5, (0, 7)
6, 48.66 (10.30), 50, (40, 52)
13, 17.61 (27.71), 10, (5, 13)
14, 0.64 (1.39), 0, (0, 1)
14, 5.21 (5.53), 3.5, (2, 4)
11, 1,134.55 (952.93), 887, (511, 1405)
14
0
9
5

ART adult services
Yes
No

14
0

Pediatric ART services
Yes
No

14
0

Follow up mechanisms
Active
Passive

8
6
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Program retention
Health facility retention; women: The retention levels of the women by the specified time intervals are
presented in Table 17. About 35 percent of the women returned to the same facility 30 days after
registration. At delivery, however, 62 percent of the registered women were retained, but by 9–10 months
only 34 percent were retained.
Table 17 Retention of women by specified time intervals
N expected
600
624
384
384
384
384

N observed
209
384
147
186
165
151

Time period
30 days
Delivery
6 wks
2–4 m
5–7 m
9–10 m

Prop.
0.35
0.62
0.28
0.36
0.31
0.34

95% CIs
0.31, 0.39
0.58, 0.66
0.23, 0.33
0.32, 0.41
0.27, 0.37
0.29, 0.39

Health facility retention; infants: The retention of infants by specified time intervals is presented in Table
18. Only 14 percent were returned to the same health facilities at 6 weeks of age, though this proportion
increased to 23 percent at 2–4 months, and then decreased to 11 percent at 9–10 months.
Table 18 Retention of infants by specified time intervals
N expected
624
624
624
624

N observed
91
141
130
71

Time period
6 wks
2–4 m
5–7 m
9–10 m

Prop.
0.14
0.23
0.21
0.11

95% CI
0.88, 0.23
0.15, 0.34
0.14, 0.32
0.14, 0.24

Demographic and clinical characteristics associated with retention
Due to the paucity of data on these characteristics, we examined retention by ANC visits only for the
current pregnancy for the women; these findings are presented in Table 19.
At all specified time intervals, ANC visits were associated with retention, where women who had 3–4
visits were better retained than women who had 1–2 visits, p<0.05.
Table 19 Retention at specified time intervals by ANC visits for current pregnancy

Time
30 days
Delivery
6 wks
2–4 m
5–7 m
9–10 m

ANC visits 1–2

ANC visits 3–4

Prop

95% CI

Prop

95% CI

p-value

0.24
0.49
0.30
0.36
0.32
0.35

0.18, 0.33
0.41, 0.59
0.25, 0.38
0.30, 0.43
0.27, 0.39
0.27, 0.44

0.43
0.72
0.42
0.55
0.48
0.54

0.38, 0.49
0.66, 0.79
0.36, 0.48
0.49, 0.61
0.44, 0.53
0.47, 0.61

<0.001
<0.001
0.012
<0.001
<0.001
<0.001
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Retention by facility characteristics
We used GEE modeling to assess facility and other characteristics associated with retention. The GEE
assumes a Poisson distribution with the log link and unstructured variance-covariance for the dependent
variable. We considered the following variables: medical assistants, trained health care workers (HCWs),
facility location, number of deliveries, ANC visits, and number of HIV-positive pregnant women. Tables
20 and 21 present these findings for women and infants respectively.
Rural location and number of ANC visits were positively associated with retention, while lower numbers
of HIV-positive pregnant women, medical assistants, and trained health care workers were negatively
associated with retention. Women in rural facilities were nearly 60 percent more likely to be retained than
women in urban facilities.
Table 20 Characteristics associated with retention among women
Variable

Parameter
estimate

Standard
error

Intercept

1.015

0.139

0.408
0.169
-0.040
-0.002
-0.0003

0.091
0.038
0.010
0.001
0.0001

Facility location (rural)
No. of ANC visits
No. of medical assistants
No. of trained HCWs
No. of HIV+ pregnant women

OR

1.579
1.184
-1.041
-1.002
-1.0003

95% CI on OR/
parameter
estimate*
-1.284, -0.747

p-value

1.354, 1.840
1.097, 1.276
-1.062, -1.020
-1.005, -1.0006
-1.0006, -1.00009

<0.001
<0.001
<0.001
0.013
0.032

<0.001

For infants, not paying for services was negatively associated with retention, as were lower numbers of
medical assistants, clinical officers, and trained health care workers. As with the women, attending more
ANC visits was associated with retention, as were more trained nurses. Infants attending rural facilities
were two and one half times more likely to be retained compared with those attending urban facilities.
Table 21 Characteristics associated with retention among infants
Variable

Parameter
estimate

Standard
error

Intercept

-2.817

0.177

Facility location (rural)
Pay for service (no)
No. of ANC visits
No. of trained nurses
No. of medical assistants
No. of clinical officers
No. of trained HCWs

0.925
-0.449
0.337
0.061
-0.113
-0.119
-0.006

0.176
0.136
0.052
0.003
0.015
0.021
0.002

OR

2.523
0.638
1.401
1.063
-1.119
-1.126
-1.006

95% CI on OR/
parameter
estimate*
-3.165, -2.470

p-value

1.785, 3.566
0.488, 0.833
1.315, 1.618
1.055, 1.071
-1.155, -1.087
-1.175, -1.079
-1.010, -1.002

<0.001
<0.001
<0.001
<0.001
<.0001
<0.001
0.004

<0.001
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Discussion
According to the Government of Malawi MOH Integrated HIV Program Report, July–September 2013,
72 percent of women enrolled on ART were retained at 12 months (Government of Malawi, MOH
2013b). A paper published by Tenthani et al. (2014) found that retention of Option B+ patients at 6
months was estimated to be 76 percent from electronic patient record data and 82 percent from nonelectronic patient records. Our findings of retention of about 31 percent at 6 months, and 34 percent
at 9–10 months are at variance with the reported national estimates. Explanations for these differences
include site performance variations, different data sources, sample sizes, data quality and completeness,
timing of the study framework, and definitions of retention.
Site performance variations: In general in Malawi, there is a sizeable variation in site performance as
documented in the MOH quarterly supervision visits/ reports, according to the MOH July–September
2013, Integrated HIV Program Report (2013b). This study sampled 14 sites of 675 static sites. Sites were
selected for the study based on patient load and HIV prevalence regardless of performance.
Data sources: The MOH measures PMTCT/ART retention from the ART register as the entry point,
whereas we used ANC and maternity registers as the entry points. The objective of the study was to assess
the retention on ART of the HIV-positive mothers starting from pregnancy to delivery and postnatal care.
Hence the ANC register was used as an entry point and the maternity register was also used to capture
information about delivery. Ultimately this should not matter as all persons on ART (including pregnant
and lactating women) are referred to the ART clinic after delivery and/or breastfeeding. However, there
are more steps in the documentation process to go from ANC to ART (than a patient initiating ART in
ART) and therefore some women and/or records may not transfer. In addition, the ART records are of
higher quality because of the many years of intense supervision and data quality checks, which are not
systematically done in ANC and maternity register; therefore the ANC/maternity records tend to have
more missing and inaccurate information.
Sample size: This study sampled 14 facilities, whereas the MOH reviews retention in all 675 facilities
offering ART. This could mean that some women seen in ANC at a study site moved to another nonstudy site for delivery and/or subsequent ART services. This cannot be determined when reviewing results
at 14 facilities, but may be determined when reviewing results at all facilities in the country. This is one of
the study limitations.
Data quality and completeness: EGPAF has observed data quality issues within and independent of this
study related to human resource limitations, knowledge and training on the completion of national
data tools, data use, and other factors. The MOH records data quality issues in their quarterly quality
improvement reports. The proportion of sites with data quality issues varies, but in the MOH Quarter
3, 2013 Quality Improvement report, there were over 400 sites identified (out of 675) with data
completeness and/or quality issues (Government of Malawi, Ministry of Health 2013a).
Timing of the study frame: We sampled cohorts of women from sites during the October to December
2011 and January to March 2012 time period. This corresponds with the first one to six months of the
rollout of Option B+ in Malawi. An analysis completed but not presented found that there was lower
retention in the October to December period compared with the January to March period, but that this
was limited. There had been insufficient beneficiary and community preparedness and communication
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prior to the rollout (UNAIDS 2011). This was later rectified through community sensitizations. However,
very early on, some women identified as HIV-positive in pregnancy and instructed to start ART for
life were reluctant and rather than refuse treatment, disposed of the ARVs (based on anecdotal stories
from implementing partners’ observations). A recent presentation suggested that stigma, confidentiality,
privacy, and the method of initiating ART continue to challenge PMTCT services in Malawi (Cataldo et
al. 2013).
Definition of retention: The definition of retention in this study was more specific and restrictive than
is generally used to calculate retention in a programmatic setting. Retention in the study was based on
the dates indicated in the patient card for drug pickups. The study considered women to be retained on
ART only if she adhered to the schedule for drug pickup as documented in the patient card or register.
Retention in programmatic settings is typically a calculation of individual alive and current on ART in a
given period.
Tenthani and Haas, in reviewing data for the period October 2011–March 2012 for 21,939 patients
from 540 nationally representative facilities as well as 11,534 patient records from the electronic medical
record system from 19 large facilities, also found that compared to ART patients in an advanced stage
of the disease, Option B+ patients are at increased risk of loss to follow-up and that pregnant Option
B+ patients are at particularly high risk to get lost. In addition, most Option B+ patients who were lost
started at the day of HIV testing and never came back. This finding was supported by Coulborn in a
study of a rural district in Malawi (Coulborn et al. 2013). Our data show that a large proportion of the
women indeed were lost to follow up soon after testing and being enrolled in the PMTCT/ART program.
We found rural sites to be at least twice as likely to retain mothers and infants. This is consistent with
Tenthani et al.’s (2014) findings that urban sites tended to have higher loss to follow up (OR: 1.4, [1.0–
2.0]) compared to rural sites. Lower numbers of trained health workers, medical assistants, and HIVpositive pregnant women may be associated also with the smaller (rural) health facilities. Our findings
of an association between smaller centers as measured by smaller numbers of health workers is consistent
with a report of the success of a Rwanda program for HIV-infected children on ART by McNairy et al.
(2013).
Health services in the public facilities are free, so the finding that infant retention was associated with
payment services is an indicator of faith-based managed facilities. Our finding is consistent with Tenthani
et al.’s (2014) finding that faith-based managed facilities had 19 percent better retention than publicly
managed facilities among pregnant and breastfeeding women on Option B+. Programs with active follow
up are associated with decreased patient loss to follow up (Thomson, Cheti, and Reid 2011; Tweya et al.
2010).

Kenya
Sample size
Table 22 presents the proposed sample sizes for the records of HIV-positive women to be reviewed versus
the actual sample sizes attained by type of health facility. Overall, 100 percent of the proposed sample size
was reached. The district hospitals contributed 50 percent of the total number of records sampled and the
provincial hospital contributed 28 percent.
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Table 22 Proposed versus actual sample size by type of health facility
Type of site
Provincial hospital (n=1)
District hospital (n=6)
Private hospital (n=1)
Health center (n=4)
Total (N=12)

Proposed (women)
N (%)
76 (17.76)
208 (48.60)
70 (16.36)
74 (17.29)
428 (100.00)

Actual (women)
N (%)
121 (27.88)
219 (50.46)
14 (3.23)
80 (18.43)
434 (100.00)

Background characteristics
Women: The mean age of the women was 26 years, with mean parity of 2.9, and about 90 percent were
married. Table 23 presents the demographic and selected clinical characteristics of the women. There was
no information available on education or employment. For the 367 women for whom this information
was available, 53 percent were referred to an ART initiating site; 19 percent were recorded to have had
four or more ANC visits for the current pregnancy. About 40 percent were known HIV positive at first
ANC visit and nearly 30 percent were recorded to have been CD4 tested. Only 177 women (41 percent)
had been WHO staged at baseline; of these, 85 percent were stage 1 or 2. Approximately 38 percent (98
women) were initiated on HAART, but in 40 percent of the records, this information was not available.
Among the 51 women for whom the type of HAART regimen was available, 49 percent were recorded to
be on AZT+3TC+nevirapine (NVP) and 39 percent on stavudine (D4T)+3TC+NVP.
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Table 23 Baseline characteristics of the women (N=434)
Variable
Age [n, mean (sd) median, (Q1, Q3)]
Parity [n, mean (sd), median, (Q1, Q3)]

n

%

430, 26.3 (5.20), 26(22, 30)
424, 2.9 (1.4), 3(1.0, 4.0)

Marital status (n=410)
Married
Single
Divorced/separated/widowed

373
21
16

91.0
5.1
3.9

Referral to ART initiating site (n=367)
Yes
No

195
172

53.1
46.9

Number of ANC visits for this pregnancy (n=363)
1
2
3
4 or more

163
72
60
68

44.9
19.8
16.5
18.7

Known HIV positive at first ANC (n=434)
Yes
No

172
262

39.6
60.4

CD4 tested (n=434)
Yes
No

133
301

30.7
69.3

98
53
26

55.4
29.9
14.7

98
160

38.0
62.0

Prophylaxis (n=73)
AZT
AZT+3TC
AZT+NVP
AZT+3TC+NVP
SDN

48
9
6
7
3

65.8
12.3
8.2
9.6
4.1

HAART (n=51)
AZT+3TC+NVP
D4T+3TC+NVP
AZT+3TC+EFV
AZT+D4T+EFV
ABC+3TC+NVP

25
20
4
1
1

49.0
39.2
7.8
2.0
2.0

2
131

1.50
98.50

WHO staging at baseline (n=177)
Stage 1
Stage 2
Stages 3&4
Initiated on prophylaxis or HAART (n=258)
HAART
Prophylaxis
Type of regimen

Toxicities/side effects (n=133)
Yes
No

Notes: AZT=zidovudine, 3TC=lamivudine, NVP=nevirapine, SDN=single-dose nevirapine, EFV=efavirenz, D4T=stavudine,
ABC= abacavir

Infants: Table 24 presents the description of the records of the infants. There was a significant amount of
data (over 60 percent) missing for these variables. Of the data available, nearly 80 percent of the infants
were born in a health facility, over half were male, and only 6 percent recorded delivery by Cesarean
section. Over 90 percent were recorded to have had DNA PCR, and only 10 percent had been nonexclusively breastfed.
Table 24 Baseline characteristics of the infants (N=434)
Variable

n

%

Place of delivery (n=121)
Health facility
Home

96
25

79.3
20.7

Gender* (n=181)
Male
Female

101
80

55.8
44.2

Mode of delivery (n=130)
NVD
C-section

122
8

93.8
6.2

Infant DNA PCR (n=160)
Yes
No

155
5

96.9
3.1

Mode of feeding (n=127)
Exclusive breastfeeding
Mixed feeding
Replacement feeding

111
13
3

87.4
10.2
2.4

74
25

74.7
25.3

HIV antibody testing at 18 months (n=99)
Yes
No
*One set of twins; a male and a female.

Characteristics of the health facilities: The sampled health facilities included eight hospitals and four health
centers. One hospital was a privately-run facility; the remaining facilities were run by the government.
Two-thirds (8) of the facilities were located in urban areas, with the remainder rural. Table 25 presents
selected characteristics of these health facilities for 2011. The median numbers of first visit ANC clients
was 1,530; HIV-positive pregnant women, 199; deliveries, 708. The median number of health staff
per facility was 7.5 and the median number of doctors was 1.5. There was an average (median) vacancy
rate for nurses of four and an average (median) vacancy rate for doctors of one. All facilities provided
maternity services. One facility (a district hospital) experienced drug stock outs in the past three months,
though this information was not available for one facility. All except one facility provided both adult and
pediatric ART services. There was no information on CD4 TAT. Nine facilities indicated they had active
follow-up mechanisms, with the follow up starting within a week in two and after more than a week in
seven facilities.
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Table 25 Description of health facilities (N=12)
n
Number of ANC clients 2011 [n, mean (sd), median
(Q1, Q3)]
Number of HIV+ pregnant women 2011 [n, mean (sd),
median (Q1, Q3)]
Number of deliveries [n, mean (sd), median (Q1, Q3)]
Number of health staff [n, mean (sd), median (Q1,Q3)]
Number of doctor last quarter [n, mean (sd), median
(Q1, Q3)]
Vacancy rates: nurses [n, mean (sd), median (Q1, Q3)]
Vacancy rates: doctors [n, mean (sd), median (Q1, Q3)]

12, 1729.8 (1165.5),1530 (905.5, 2416)
12, 1212.5 (1673.5), 199 (51, 2319)
12, 1355.4 (1725.4),708.5 (393.5, 1287.5)
12, 15.9 (18.3), 7.50 (5, 22)
12, 6.4 (14.9), 1.50 (0, 4)
12, 9.3 (13.1), 4 (3, 7)
11, 2.6 (3.9), 1 (0, 8)

ART drug stock outs last 3 months
Yes
No
Missing

1
9
1

Follow up mechanisms
Active
Passive

9
3

If active, when does follow-up mechanism start
Less than a week
More than a week

2
7

Program retention
Health facility retention; women: We examined retention of women overall and on HAART specifically, as
under Option A, these women should be followed over time, including postnatal. Table 26 presents these
data.
Table 26 Retention of women overall and on HAART by specified time intervals
Expected
434
434
182
182
182
182

Observed
79
122
39
57
30
4

Time
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

Overall

On HAART

Prop

95% CI

Prop

0.18
0.28
0.21
0.31
0.16
0.02

0.14, 0.21
0.24, 0.32
0.16, 0.28
0.25, 0.39
0.12, 0.23
0.01, 0.06

0.41
0.42
0.40
0.59
0.25
0.03

95% CI

0.33, 0.52
0.34, 0.53
0.29, 0.54
0.48, 0.73
0.16, 0.39
0.008, 0.126

For the 30 day, delivery, and 6 week visits, about 40 percent of the women on HAART were retained,
and at the 2–4 month visit, this increased to nearly 60 percent. Thereafter, the proportion declined to 25
percent, and subsequently to 3 percent at 11–13 months.
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Health facility retention; infants: Table 27 shows the infant retention by specified time period. The highest
proportion of infants retained (16 percent, 12–21) was at 2–4 months after delivery.
Table 27 Retention of infants by specified time intervals
Expected
434
434
434
434

Observed
43
70
57
7

Time
6 wks
2–4 m
5–7 m
11–13 m

Prop
0.10
0.16
0.11
0.01

95% CI
0.07, 0.14
0.12, 0.21
0.07, 0.17
0.00, 0.03

Demographic and clinical characteristics associated with retention
We examined retention levels by selected demographic and clinical characteristics. These characteristics
were referral to ART initiating site and number of ANC visits for the current pregnancy, (<3, 3+). The
findings are presented in Tables 28–29.
At delivery, women who were not referred were better retained, p<0.001 (Table 28). However, referred
women had better retention levels at 6 weeks and 2–4 months, p=0.008, p=0.014, respectively.
Table 28 Retention at specified time intervals by referral to ART initiating site
Time

Referred
Prop
95% CI

Did not refer
Prop
95% CI

p-value

30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

0.15
0.22
0.31
0.42
0.19
0.04

0.22
0.38
0.14
0.24
0.16
0.01

0.073
<0.001
0.008
0.014
0.639
0.335

0.11, 0.21
0.16, 0.28
0.23, 0.43
0.33, 0.54
0.12, 0.30
0.01, 0.11

0.17, 0.29
0.31, 0.46
0.08, 0.24
0.16, 0.36
0.10, 0.27
0.001, 0.09

At all time periods, except for 11–13 months (which had very limited data), women with 3–4 ANC
visits had higher retention proportions, though these reached statistical significance only for the 30 days,
delivery, and at 6 weeks visits, p<0.05. Table 29 presents these data.
Table 29 Retention at specified time intervals by ANC visits for current pregnancy
Time
30 days
Delivery
6 wks
2–4 m
5–7 m
11–13 m

ANC visits 1–2
Prop
95% CI

ANC visits 3–4
Prop
95% CI

p-value

0.04
0.12
0.09
0.19
0.13
0.03

0.26
0.39
0.24
0.34
0.17
0.02

<0.001
<0.001
0.042
0.091
0.503
0.693

0.03, 0.06
0.07, 0.19
0.03, 0.29
0.09, 0.39
0.04, 0.39
0.01, 0.19
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0.18, 0.35
0.25, 0.60
0.13, 0.43
0.22, 0.53
0.09, 0.35
0.01, 0.05

Retention by facility and other characteristics
As mentioned previously, we used GEE modeling to assess the characteristics associated with retention.
In addition to referral for initiation and number of ANC visits, the facility characteristics of location,
numbers of first ANC visits, HIV-positive pregnant women, deliveries, nurses, doctors, health staff, and
follow up mechanism, whether active or passive, were included in the model. These findings are presented
in Table 30. Facility location, type of follow-up mechanism, and number of facility doctors were
associated with retention. Women in urban facilities were 22 percent less likely to attend visits compared
to those from rural facilities, with an OR of 0.78 (0.62, 0.98). Women who attended facilities with
active follow up mechanisms were more likely to attend visits compared to those who attended facilities
with passive follow up mechanisms, OR: 1.83, (1.42, 2.35). Similarly, the likelihood of attending health
facility visits increased with the number of doctors, OR: 1.01 (1.00, 1.01).
Table 30 Characteristics associated with retention among women
Variable

Facility location (urban)
Follow up mechanism (active)
No. of doctors

Parameter
estimate

Std error

OR

-0.244
0.603
0.008

0.116
0.127
0.002

0.782
1.827
1.008

95% CI on OR/
parameter
estimate
0.623, 0,983
1.423, 2.346
1.003, 1.013

p-value

0.035
<0.001
<0.001

Discussion
The reportedly low retention rates among both the women and the infants is likely due to the movement
of women between facilities, and perhaps poor record-keeping. Women attending ANC in one facility
but choosing to deliver in another facility is a practice that has been found in other countries. A study in
Zimbabwe found that though delivery facilities were available in the rural health centers, many women
chose to deliver at the district or mission hospitals, despite the longer distances, possibly because of the
perception of better services, including the presence of doctors (Muchedzi et al. 2013). In addition,
Kenya, as an Option A country, does not specifically track HIV-positive pregnant women. A study of
two government hospitals found inaccurate recording and reporting of PMTCT data, where register data
indicated that about a third of the women attending ANC were not given maternal prophylaxis (Ferguson
et al. 2012). Interviews with the nurses revealed that they sometimes failed to record the provision of
prophylaxis despite actually giving it. Though not strictly comparable, Kenyan children under the age of
one year on ART were reported to have a rate of 70 percent retention in care in a multi-country study
(McNairy et al. 2013). The data in the multi-country study came from a collaboration (Identifying
Optimal Models of HIV Care and Treatment Study, 5U2GPS001537-03), which had resources to invest
in improving training, oversight, and documentation, including electronic patient-level databases. Thus
these findings probably do not represent the operational status of retention. EGPAF 2011 aggregate data
for HIV-exposed infants showed that the retention rate at 18 months was 42 percent (EGPAF 2011).
Data for 12 months retention were not available. Women who attended more ANC visits were better
retained than women who attended fewer.
However, women on HAART are tracked, and while these retention levels were also relatively low,
they decreased precipitously after 3 months post natal. This may have been because these women were
transferred for follow-up at the ART clinics, and were therefore no longer available in the MCH clinics.
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Referral is associated with post-delivery visits. As Kenya transitions to the Option B+ regime, greater
attention will need to be given to the tracking of mother/infants pairs, including improved registers
accompanied by enhanced training and supervision of the health staff and the development of a culture of
information use.
Overall, retention was associated with rural location, active follow up, and more doctors. This suggests
that there may be less mobility in rural facilities compared to urban ones. This also suggests that active
follow-up is more effective than passive follow up, and that facilities with more doctors may be better
resourced or have been services, and this is important to the women. Programs with active patient followup may be more effective in reducing loss to follow up and subsequently improving retention (Thomson,
Cheti, and Redi 2011; Tweya et al. 2010). District/provincial hospitals, where clients are more likely to be
referred for treatment and follow-up, are more likely to have more doctors than lower level facilities.

Swaziland
Sample size
Table 31 presents the number of records of the women sampled by type of health facility. The 12 clinics
contributed 41 percent of the sample, while the two PHUs contributed 26 percent of the records. While
a sample size of 500 records was estimated, the study team extracted data on all women attending selected
health facilities during the specified time period, leading to a sample size of 2,129.
Table 31 Sample size by type of health facility
Type of facility
Primary health unit
Health center
Clinic
Unknown
Total

Number of
health facilities
2
2
12
16

Women sampled
N (%)
555 (26.1)
700 (32.9)
872 (40.9)
2 (0.1)
2,129 (100.0)

Background characteristics
Women: The mean age of the women was 26.5 years, with mean parity of 1.7. There was no information
on education, employment status, or women referred to ART initiating site. Table 32 presents the
demographic and selected clinical characteristics of the women. About a third (32 percent) were recorded
as having had the recommended four or more ANC visits for this pregnancy, and 78 percent were known
to be HIV positive at the first ANC visit, though these data were missing in about 32 percent of the
records. About 68 percent of the women had been CD4 tested and 96 percent were WHO stage 1 or 2 at
baseline. About a quarter (27 percent) of the women were on HAART at entry into the program.
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Table 32 Baseline characteristics of the women (N=2,129)
n
Age [n, mean (sd) median, (Q1, Q3)]
Parity [n, mean (sd), median, (Q1, Q3)]
Number of ANC visits for this pregnancy (n=2,111)
0
1
2
3
4 or more

%

2115,26.5 (5.5), 26 (22,30)
2118, 1.7 (1.5), 1 (1,2)
1
494
433
498
685

0.01
23.4
20.5
23.6
32.4

Known HIV positive at first ANC (n=1,458)
Yes
No

1,134
324

77.8
22.2

CD4 tested (n=2,129)
Yes
No/missing CD4 count

1,456
673

68.4
31.6

WHO staging at baseline (n=1,576)
Stage 1
Stage 2
Stage 3 or 4

1,310
204
62

83.1
12.9
4.0

On HAART at entry (n=1,804)
Yes
No

487
1,317

27.0
73.0

HAART eligible (n=1,718)
Yes
No

425
1,293

24.7
75.3

Infants: Table 33 presents the background characteristics of the infants. About half the infants were
male (51 percent) and 10 percent were delivered by Cesarean section. The mean birth weight (standard
deviation) for infants was 3,100 grams (600; 6.8 pounds). There was no information on place of delivery.
Over 90 percent were recorded to have had the DNA PCR test and 90 percent were given CTX.
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Table 33 Baseline characteristics of the infants (N=1,740)
Gender (n=1,730)
Male
Female
Mode of delivery (n=2,021)
Normal vaginal delivery
C-section
Birth weight [n, mean (sd), median, (Q1, Q3)]

n

%

884
846

51.1
48.9

1,791
214

89.4
10.7

1,512, 3.11 (0.55), 3.10 (2.80, 3.50)

Infant DNA PCR (n=1,740)
Yes
No

1,589
115

93.3
6.8

CTX supplementation (n=1,740)
Yes
No

1,471
170

89.6
10.4

Characteristics of the health facilities: Of the 16 health facilities sampled, nine were rural and the
remainder urban. Two of the facilities were private (faith-based) and the remainder government-run. In
seven facilities, there was payment for services. Table 34 presents selected characteristics of these health
facilities for the year 2011. The median number of first visit ANC clients was 282 and the median
number of HIV-positive pregnant women was 115. The median number of deliveries in the five facilities
that carried out deliveries was 72 for the year, and the median number of PNC clients was 152. The
median number of clinical staff was five, and six facilities had two or more vacancies. Only one facility
experienced drug stock outs in the past three months, and 11 facilities were ART initiating sites, provided
both adult and pediatric ART services; one site provided adult but not pediatric services. Concerning the
CD4 test turnaround times (TAT), eight sites did this within three days, and eight took up to two weeks.
All facilities indicated that they had active follow-up mechanisms using cell phones.
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Table 34 Description of the health facilities (N=16)
n
Number of ANC clients, 2011 [n, mean (sd), median (Q1, Q3)]
Number of HIV+ pregnant women, 2011 [n, mean (sd),
median (Q1,Q3)]
Number of deliveries, 2011 [n, mean (sd), median (Q1,Q3)]
Number of PNC clients, 2011 [n, mean (sd), median (Q1, Q3)]
Number of clinical staff, 2011 [n, mean (sd), median (Q1, Q3)]
Staff vacancies in 2011, by number of facilities
0
1
2
4

16, 592.1 (871.6), 282.5 (126.5, 760)
16, 163.2 (155.5), 115 (46.5, 233.5)
5, 255.4 (364.4), 72 (10, 330)
16, 287.8 (251.9), 152 (80.5, 481.5)
16, 5.9 (4.1), 5.0 (3.5, 6.0)
7
2
5
1

Maternity services provided
Yes
No

5
11

ART drug stock outs last 3 months
Yes
No

1
15

ART adult services
Yes
No

12
4

Pediatric ART services
Yes
No

11
5

ART initiating sites
Yes
No
Unknown

11
4
1

CD4 TAT*
Same day
2–3 days
1 week
2 weeks

6
2
7
1

Turn-around-time: This is the amount of time taken from collection of samples at the health facility to the availability of the
test results at the same health facility.

*

Program retention
We were unable to link ANC data with delivery and PNC data for the women because of the lack of
unique identifiers on the paper-based tools, and because there are only five maternity centers in the
whole country. While in the ANC registers women were identified using ANC number, the assigning of
this number was not unique across the different facilities. The ANC number was composed of a client’s
sequence number in the month, followed by the month and the year. For example, 023/05/11 is 23rd
ANC client in the month of May and year 2011. Assigning the ANC number this way resulted in a
number of women from different facilities having the same ANC number. To overcome this, we included
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other background variables such as area of residence, parity, and age to match and link the women at
least from ANC to maternity. Thus we took all the HIV-positive pregnant women enrolled during the
period for data abstraction and attempted to match the records on the selected variables and remove all
unmatched records to be able to reach the required sample size. However, this did not work, as there were
multiple duplicates of the background variables and we ended up with the large sample size. There were
also multiple versions of the registers over the period of the data abstraction with different data elements.
It was impossible to match ANC records with PNC and mother-baby-pair in child welfare registers, as
ANC numbers were missing from both PNC and CWC records. Therefore we present retention levels for
the infants only. Table 35 presents retention of infants by the specified time intervals.
Table 35 Retention of infants by specified time intervals
Expected
1,839
1,839
1,839
1,821
1,698

Observed
1,471
1,142
372
255
107

Time period
6 wks
2–4 m
5–7 m
8-10 m
11–13 m

Prop
0.80
0.61
0.20
0.14
0.063

95% CI
0.69, 0.94
0.51, 0.73
0.13, 0.32
0.075, 0.26
0.027, 0.14

At 6 weeks, 80 percent of the infants were retained in the program; this declined to 61 percent at 2–4
months, but then declined sharply to 20 percent at 5–7 months. At 12 months, the percentage of infants
retained was only 6 percent.

Retention by facility and other characteristics
As mentioned previously, we used GEE modeling to assess the characteristics associated with retention.
We modeled location (urban/rural) and ANC volume (high/low), as defined as below or above the mean.
We found no association between retention and these variables.

Discussion
The inability to effectively track women from the prenatal to the postnatal periods and to link mother/
baby pairs represents a significant limitation to PMTCT program monitoring and evaluation. The
Option A strategy acknowledged the logistical difficulties of tracking mothers over time, and thus did not
attend to this process; focusing instead on the highest period of mother-to-child transmission risk (the
antenatal period), while attempting to counter the risk from breastfeeding with feeding guidelines and
use of extended NVP. Infants were more likely to return to the health facility regularly due to established
immunization and growth monitoring clinics, so the mothers would be able to collect the NVP at the
same time. In this study, however, only 60 percent returned at 2–4 months, and by 6 months, 80 percent
were lost to follow up. As a number of women breastfeed until at least 12 months, this suggests that
there may be ongoing HIV transmission risk through breast milk. Over 70 percent of mothers were still
breastfeeding infants at 12–17 months; this declined to 38 percent at 18–23 months (Central Statistical
Office/Macro International Inc. 2008). However, these infants may have simply been lost to follow up at
that particular facility, and may have been receiving care elsewhere. This finding also reinforces the need
to track babies and mothers over time and across facilities. With the movement to Option B+, the need to
track mother/infant pairs will be more important, similar to Kenya.
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summary and
Conclusion
In summary, we found retention rates to be lower than expected and that health facility characteristics
may be important in retention. However, except for rural location, the specific association of these factors
with retention was contextual and differed by country.

Limitations

A limitation of the study design is that except for Swaziland, the facility sampling methodology
was purposive and excluded very low volume sites, thus having the potential for bias toward higher
workload facilities which may have more staff. Also, we cannot assess the degree to which the findings
may be representative of particular facilities or geographical areas because of the lack of randomization.
Additionally we did not assess the socioeconomic status of women that participated in this study. A
strength of the study is that it was carried out in multiple sites in a number of countries, increasing the
likely validity of the main findings.

Discussion

The implication of these findings for the implementation of Option B+ shows the need for a greater focus
on the ability to track and trace clients over time and place. This is especially true given that they will be
on ARV drugs for life and that careful attention needs to be paid to specific health facility characteristics
which can facilitate or constrain retention. Under the Option A protocol, HIV-positive pregnant women
were essentially discharged from the health facility after they had delivered. The lower-than-expected levels
of retention may be related to the inability to track the women across facilities as well as the difficulty in
tracking the women across the different clinics in the PMTCT program. In our study, retention refers
to a woman being found/retained in a particular facility, yet while she may not be found in the records
for that facility, she may be receiving services elsewhere and thus still being retained in the program. For
various reasons a woman may choose or be referred to another facility, and currently there is no system
that adequately tracks women across facilities. Additionally, and of special importance, is the difficulty of
tracing women across the multiple registers and files. In order to assess whether a particular woman may
be retained even in a particular facility she needs to be traced from the ANC register through, in some
cases, to the PMTCT register, to the labor and delivery register, to the postnatal register, etc. There needs
to be a unique identifier (such as ANC or PMTCT number) to facilitate this process, and as the system
is manual and paper-based, transcription errors are likely to occur. In addition, the limited numbers of
often over-worked health care workers need to document information in these various registers and files,
sometimes duplicating the information in several places. This combined with the large number of data
fields required leads also to the situation of missing data and misplaced or lost registers or patient files
and consequent data quality challenges. In many instances, for example, key variables were missing data,
in some cases substantial amounts, making that particular variable less useful in the analysis and making
interpretation of findings problematic.
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Conclusion

Potential solutions to these difficulties include improving the patient recording system by reducing
the multiple required recording documents to one. Data quality might be improved by integrating
patient records and reducing the number of data elements to the most critically important ones.
Electronic patient records have the potential to facilitate this process. However, the cost and logistics
of implementing this in every site would be very challenging. At a minimum however, a surveillance
system in selected sites on a district or regional basis to include the district or referral hospital could be
implementable. There would still be, however, the challenge of the unique identification of each motherbaby pair and tracking and tracing of mothers from ANC to labor and delivery and into the PNC period.
Many women choose or are referred to secondary level facilities such as district hospitals for their delivery.
They thus need to be tracked and traced there, which may be difficult as women come from various
ANC facilities and their ANC and PMTCT numbers may not be unique. This is because these numbers
are allocated by each ANC facility independently. This situation is compounded in places where many
women have the same surname and even the same first name, or even change their surname by that
time, making tracking and tracing very difficult. Clearly there is a need for developing a national unique
identification system, which would be a combination of the ANC/PMTCT number, facility number,
date and women’s age. In countries with national registration numbers, consideration could be given to
utilizing this system, though not every woman necessarily has a number.
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